行情

PRPH

PRPH

Prophase Lab
NASDAQ

实时行情|Nasdaq Last Sale

1.870
+0.242
+14.89%
已收盘, 16:00 09/18 EDT
开盘
1.770
昨收
1.628
最高
1.890
最低
1.770
成交量
1,726
成交额
--
52周最高
3.705
52周最低
1.628
市值
2,162.65万
市盈率(TTM)
-5.9936
分时
5日
1月
3月
1年
5年

PRPH 新闻

  • 连续三天!美联储计划再进行750亿美元隔夜回购操作
  • 新浪财经综合.2小时前
  • 微软宣布400亿美元股票回购 盘后股价上涨1.3%
  • 新浪美股.3小时前
  • 新iPhone预售“真香” 苹果公司却一年痛失三位高管
  • 新浪美股.3小时前
  • 罢工导致工厂放缓 通用汽车在加拿大临时裁员1200人
  • 新浪美股.3小时前

更多

所属板块

食品加工
-0.37%
食品和烟类
-0.41%

热门股票

名称
价格
涨跌幅

PRPH 简况

ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The Company's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.
展开

Webull提供ProPhase Labs Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。